Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000607 · ClinicalTrials.gov registry record · Phase 3
Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH)
A Phase 3 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 3
- Development phase
- 129
- Enrollment target
NCT00000607 is a Phase 3 study that has completed, run by Columbia University. The registered enrollment target is 129 participants.
The verdict
NCT00000607, a Phase 3 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 129 participants
- Enrollment target
Study Summary
To conduct a randomized, unblinded clinical trial comparing the left ventricular assist device (LVAD) with maximum medical management in patients with end-stage heart failure who were not candidates for heart transplantation.
Interventions
- DEVICE Left ventricular assist device
- DEVICE Optimal medical therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 1997-10 |
| Est. Completion | 1999-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000607
The ClinicalTrials.gov registry entry for NCT00000607 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Left ventricular assist device is the first listed.
NCT00000607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000607 about?
NCT00000607 is a clinical study titled "Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH)". To conduct a randomized, unblinded clinical trial comparing the left ventricular assist device (LVAD) with maximum medical management in patients with end-stage heart failure who were not candidates for heart transplantation.
What is the current status of trial NCT00000607?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 129 participants. The study started on 1997-10. Estimated completion is 1999-03.
What interventions are being tested in trial NCT00000607?
The interventions under investigation include: Left ventricular assist device (DEVICE), Optimal medical therapy (DEVICE).
Who is sponsoring clinical trial NCT00000607?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.